Trial Profile
The effect of Orexin receptor antagonist Suvorexant on REM sleep behavior disorder
Status:
Not yet recruiting
Phase of Trial:
Phase II
Latest Information Update: 07 Jun 2021
Price :
$35
*
At a glance
- Drugs Suvorexant (Primary)
- Indications REM-sleep-behavior-disorder
- Focus Therapeutic Use
- 16 May 2017 New trial record